Ionis Pharmaceuticals Inc (NASDAQ:IONS)

42.17
Delayed Data
As of Jun 21
 -1.86 / -4.22%
Today’s Change
39.07
Today|||52-Week Range
65.51
-16.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-11.2M-4.9M-4.7M-10.8M
 
 
 
 
 
Depreciation2.4M2.6M995.0K2.8M
 
 
 
 
 
Total Other Cash Flow33.0M38.8M35.9M38.3M
 
 
 
 
 
Funds From Operations24.2M36.5M32.3M30.3M
 
 
 
 
 
Funds From/For Other Operating Expenses21.8M7.8M11.9M17.2M
 
 
 
 
 
Net Cash Flow - Operating Activities2.4M28.7M20.4M13.2M
 
 
 
 
 
 
InvestingIncrease In Investments-81.7M-243.7M-288.7M-91.2M
 
 
 
 
 
Decrease In Investments103.3M111.4M243.5M173.7M
 
 
 
 
 
Capital Expenditures-6.8M-17.7M-9.1M-3.1M
 
 
 
 
 
Net Cash Flow Investing14.7M-150.1M-54.2M79.5M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----0.000.00--
Long Term Debt Reduction-1.6M-80.4M-22.0K0.00
 
 
 
 
Net Proceeds Stock Sale3.4M168.3M4.3M5.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total------0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.7M147.6M4.3M5.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash18.8M26.2M-29.6M97.9M